MMSI
MERIT MEDICAL SYSTEMS INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$90.72
+7.79%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.6B | 1.5B | 1.4B | 1.3B | 1.2B |
| Cost of Revenue | 815.1M | 777.8M | 713.2M | 673.5M | 631.9M |
| Gross Profit | 796.0M | 736.9M | 643.3M | 583.9M | 519.1M |
| Operating Expenses | |||||
| R&D Expense | 96.9M | 97.4M | 83.8M | 82.7M | 75.5M |
| SG&A Expense | 481.8M | 455.2M | 376.7M | 373.7M | 342.5M |
| General & Admin Expense | 46.9M | — | — | — | — |
| Selling & Marketing Expense | 72.6M | — | — | — | — |
| Other Expenses | (36.0K) | — | 27.1M | 3.5M | 13.5M |
| Total Operating Expenses | 578.7M | 552.6M | 487.6M | 458.7M | 431.5M |
| Cost and Expenses | 1.4B | 1.3B | 1.2B | 1.1B | 1.1B |
| Operating Income (EBIT) | 217.4M | 184.4M | 155.7M | 123.9M | 87.6M |
| Non-Operating | |||||
| Interest Income | 15.7M | 15.1M | 26.2M | 2.5M | 439.0K |
| Interest Expense | 32.3M | 26.5M | 31.2M | 15.5M | 6.3M |
| Net Interest Income | (16.7M) | (11.4M) | (5.0M) | (13.1M) | (5.9M) |
| Other Non-Op Income/Expense | (5.7M) | (13.4M) | (5.7M) | (11.9M) | (4.9M) |
| Non-Operating Income (excl Interest) | (26.7M) | (13.0M) | (3.5M) | (3.7M) | (1.4M) |
| EBT (Pre-Tax Income) | 211.7M | 170.9M | 150.0M | 112.1M | 82.6M |
| Income Tax Expense | 51.6M | 42.4M | 29.6M | 17.7M | 8.1M |
| Bottom Line | |||||
| Net Income | 160.1M | 128.5M | 120.4M | 94.4M | 74.5M |
| Earnings from Cont. Ops | 160.1M | 128.5M | 120.4M | 94.4M | 74.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 160.1M | 128.5M | 120.4M | 94.4M | 74.5M |
| Per Share | |||||
| Basic EPS | $2.69 | $2.17 | $2.07 | $1.64 | $1.31 |
| Diluted EPS | $2.66 | $2.13 | $2.03 | $1.62 | $1.29 |
| Revenue Per Share | $26.94 | $25.60 | $23.30 | $21.83 | $20.26 |
| Shares | |||||
| Basic Shares Outstanding | 59.8M | 59.2M | 58.2M | 57.6M | 56.8M |
| Diluted Shares Outstanding | 60.4M | 60.5M | 59.4M | 58.4M | 57.7M |
| Profitability Metrics | |||||
| EBITDA | 377.5M | 332.0M | 274.0M | 228.9M | 181.2M |
| D&A | 133.5M | 134.6M | 114.7M | 101.3M | 92.2M |
| EBIT | 244.0M | 197.4M | 159.2M | 127.6M | 89.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026